Assignee
DERMIRA INC
US·18 granted patents·15 pending applications·95 citations·filing 2013–2025
Top patents by PatentIndex Score
33 records- 0197US8558008B2Crystalline glycopyrrolate tosylateDERMIRA INC·Filed 2013·Granted Oct 15, 2013·22 cites·20 claims
- 0295US9259414B2Glycopyrrolate saltsDERMIRA INC·Filed 2015·Granted Feb 16, 2016·8 cites·21 claims
- 0395US9006462B2Glycopyrrolate saltsDERMIRA INC·Filed 2014·Granted Apr 14, 2015·13 cites·24 claims
- 0495US8859610B2Crystalline glycopyrrolate tosylateDERMIRA INC·Filed 2013·Granted Oct 14, 2014·15 cites·28 claims
- 0594US9006461B2Crystalline glycopyrrolate tosylateDERMIRA INC·Filed 2013·Granted Apr 14, 2015·13 cites·18 claims
- 0688US10906871B2Processes for making, and methods of using, glycopyrronium compoundsDERMIRA INC·Filed 2017·Granted Feb 2, 2021·3 cites·37 claims
- 0787US10004717B2Glycopyrrolate saltsDERMIRA INC·Filed 2017·Granted Jun 26, 2018·5 cites·31 claims
- 0886US9926270B2Process for production of glycopyrronium tosylateDERMIRA INC·Filed 2015·Granted Mar 27, 2018·2 cites·29 claims
- 0986US9610278B2Glycopyrrolate saltsDERMIRA INC·Filed 2016·Granted Apr 4, 2017·4 cites·33 claims
- 1085US10294201B2Process for production of glycopyrronium tosylateDERMIRA INC·Filed 2018·Granted May 21, 2019·1 cites·34 claims
- 1183US9440056B2Device and method for dispensing a drugDERMIRA INC·Filed 2015·Granted Sep 13, 2016·5 cites·22 claims
- 1278US10548875B2Glycopyrrolate saltsDERMIRA INC·Filed 2018·Granted Feb 4, 2020·1 cites·27 claims
- 1377US10543192B2Glycopyrrolate saltsDERMIRA INC·Filed 2018·Granted Jan 28, 2020·1 cites·41 claims
- 1471US12502380B2MrgprX2 antagonists for the treatment of inflammatory disordersDERMIRA INC·Filed 2024·Granted Dec 23, 2025·0 cites·18 claims
- 1571US2019225580A1Process for production of glycopyrronium tosylateDERMIRA INC·Filed 2019·Application pending·0 cites
- 1670US2026027089A1MrgprX2 Antagonists for the Treatment of Inflammatory DisordersDERMIRA INC·Filed 2025·Application pending·0 cites
- 1769US10092736B2Device and method for dispensing a drugDERMIRA INC·Filed 2016·Granted Oct 9, 2018·1 cites·8 claims
- 1869US9487497B2Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylateDERMIRA INC·Filed 2016·Granted Nov 8, 2016·1 cites·18 claims
- 1966US2025352644A1Il-13 antibodies for the treatment of atopic dermatitisDERMIRA INC·Filed 2023·Application pending·0 cites
- 2063US2024425578A1Il-13 inhibitors for the treatment of prurigo nodularisDERMIRA INC·Filed 2022·Application pending·0 cites
- 2154US9745277B2Synthetic process for preparing 2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-tetradecyloxy)furan-2-carboxylateDERMIRA INC·Filed 2016·Granted Aug 29, 2017·0 cites·20 claims
- 2253US2023029266A1MrgprX2 Antagonists for the Treatment of Inflammatory DisordersDERMIRA INC·Filed 2020·Application pending·0 cites
- 2352US2023390265A1IRAK4 Inhibitors and Topical Uses ThereofDERMIRA INC·Filed 2021·Application pending·0 cites
- 2452US2023321124A1ROR gamma t Inhibitors and Topical Uses ThereofDERMIRA INC·Filed 2021·Application pending·0 cites
- 2550US2015209428A1Pharmaceutical compositions for topical delivery of photosensitizers and uses thereofDERMIRA INC·Filed 2013·Application pending·0 cites
- 2647US2022409643A1ROR Gamma T Inhibitors and Topical Uses ThereofDERMIRA INC·Filed 2020·Application pending·0 cites
- 2746US2025289882A1Il-13 antibodies for the treatment of atopic dermatitisDERMIRA INC·Filed 2022·Application pending·0 cites
- 2845US2023125380A1Topical Compositions Comprising IRAK4 Inhibitors for Use in Treating Dermatological Conditions Characterised by InflammationDERMIRA INC·Filed 2020·Application pending·0 cites
- 2943US2023027929A1MrgprX2 Antagonists and Uses ThereofDERMIRA INC·Filed 2020·Application pending·0 cites
- 3042US2023002336A1MrgprX2 Antagonists and Uses ThereofDERMIRA INC·Filed 2020·Application pending·0 cites
- 3137US2018028487A1Dermatological formulations of 2-(2-ethoxy-2-oxoethyl)(methyl)amino-2-oxoethyl 5-(tetradecyloxy)furan-2-carboxylateDERMIRA INC·Filed 2017·Application pending·0 cites
- 3236US2016058735A1Methods of treating hyperhidrosisDERMIRA INC·Filed 2015·Application pending·0 cites
- 3334US9975867B2Synthetic process for preparing 2-furoic acid derivativesDERMIRA INC·Filed 2016·Granted May 22, 2018·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when DERMIRA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →